# COMETRIQ

NDC: 42388-012
Generic name: cabozantinib
Labeler / Manufacturer: Exelixis, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20121129

FDA application: NDA203756

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42388-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42388-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a0c3bea-c87b-4d25-bb44-5f0174da6b34